ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Apple, F.
Right arrow Articles by Dietzler, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Apple, F.
Right arrow Articles by Dietzler, D.
Annals of Clinical and Laboratory Science, Vol 12, Issue 5, 398-402
Copyright © 1982 by Association of Clinical Scientists


Articles

Elevation of creatine kinase BB CK in hospitalized patients. Importance of distinguishing BB CK from MB CK

FS Apple, NS Greenspan, and DN Dietzler

Nine hundred and forty patients (1023 samples) were analyzed by cellulose acetate electrophoresis for creating kinase MB (MB CK) in the routine clinical chemistry laboratory during screening for acute myocardial infarction. Thirty patients showed the presence of BB CK and the associated disease states were identified. Rigid criteria were applied to demonstrate the activity observed was genuinely BB CK. It is noted and demonstrated that careful attention must be paid to the methodology used to distinguish CK isoenzymes, because some assays do not differentiate between BB CK and MB CK. It was shown by us that the false positive rate for MB CK could be as great as 19 percent in laboratories using non-discriminant assays for MB CK. Thus, the laboratory must know the limitations of the assays employed to avoid potential errors in MB CK results that could be misused as biochemical evidence of a myocardial infarction.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1982 by the Association of Clinical Scientists.